The editor's roundtable: medical management of atrial fibrillation.

The American journal of cardiology

Volumn 109, Issue 4, 2012, Pages 563-569

  Friedewald, Vincent E ^a   Kowal, Robert C ^b   Olshansky, Brian ^b   Yancy, Clyde W ^b   Roberts, William C ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BLOOD; CATHETER ABLATION; DIABETES MELLITUS; DIASTOLE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART STROKE VOLUME; HUMAN; LESIONS AND DEFECTS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; STROKE; SYSTOLE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETER ABLATION; DIABETES MELLITUS; DIASTOLE; DILATATION, PATHOLOGIC; HEART ATRIA; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEDICATION ADHERENCE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; STROKE; STROKE VOLUME; SYSTOLE;

MLCS; MLOWN;

EID: 84859388701     PISSN: None     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.11.013     Document Type: Article

References (0)